Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.

Breast Cancer Update
Claim This Podcastby Dr. Neil Love
Podcast Authority
Beta
Podcast Overview
Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.
Language
🇺🇲
Publishing Since
6/1/2006
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
Reach the team behind Breast Cancer Update
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes

June 2, 2026
Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper
Professor Bernd Kasper from the Mannheim Cancer Center shares insights on current and emerging desmoid tumor treatments in this interview.

April 30, 2026
Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
<p>Dr Aditya Bardia from the University of California Los Angeles and Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding the use of oral SERDs in the management of breast cancer. </p><p>CME information and select publications <a href="http://m.researchtopractice.com/YIR2025/OralSERDsBreast" rel="noopener noreferrer" target="_blank">here</a>. </p>

April 16, 2026
HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making
Dr. Seth Wander of Massachusetts General Hospital discusses optimizing biomarker assessment for HR-positive metastatic breast cancer treatment decisions in this interview.
554 total episodes available with 2 transcripts
Recent guests on Breast Cancer Update
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Bernd Kasper
Guest
Harold Burstein
Guest
Javier Cortés
Guest
Rebecca Dent
Guest
Kevin Kalinsky
Guest
Joyce O’Shaughnessy
Guest
Dr Patrick Y Wen
Guest
Dr Rinath M Jesselsohn
Guest
Similar Podcasts
Discover related shows you might enjoy

Two Onc Docs
Sam and Karine

Gastrointestinal Cancer Update
Dr. Neil Love

Oncology Today with Dr Neil Love
Dr. Neil Love

Lung Cancer Update
Dr. Neil Love

Research To Practice | Oncology Videos
Dr Neil Love

Prostate Cancer Update
Dr. Neil Love

Hematologic Oncology Update
Dr. Neil Love

ASCO Daily News
American Society of Clinical Oncology (ASCO)

Breastcancer.org Podcast
Breastcancer.org

Oncology Brothers
Oncology Brothers

ASCO Guidelines
American Society of Clinical Oncology (ASCO)

The Mel Robbins Podcast
Mel Robbins

NEJM This Week
NEJM Group

OncLive® On Air
OncLive® On Air
Deep-dive analytics for Breast Cancer Update
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Breast Cancer Update?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.